Results 181 to 190 of about 13,218 (206)

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.

Journal of Antimicrobial Chemotherapy, 2012
Philippe Flandre, Lise Cuzin, André Cabié   +2 more
exaly  

Synthesis of Darunavir

Synfacts, 2016
openaire   +1 more source

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV

Bioorganic and Medicinal Chemistry, 2007
Hiroaki Mitsuya, Arun K Ghosh
exaly  

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

HIV Medicine, 2014
Thomas N Kakuda, R Wright
exaly  

Darunavir/ritonavir

Reactions Weekly, 2018
openaire   +1 more source

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.

Clinical Infectious Diseases, 2017
Antonio Rivero, Lourdes Domínguez-Domínguez, Adrian Curran   +2 more
exaly  

Darunavir/tenofovir

Reactions Weekly, 2018
openaire   +1 more source

Darunavir/ritonavir

Reactions Weekly, 2013
openaire   +2 more sources

Cobicistat/darunavir

Reactions Weekly, 2017
openaire   +1 more source

Deuterated darunavir

2009
openaire   +2 more sources